FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
Xenon Pharmaceuticals (NASDAQ: XENE) reported Q3 EPS of ($0.36), $0.02 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $8.12 million versus the consensus estimate of $10.22 million.
Cash and cash equivalents and marketable securities as of September 30, 2021 were $249.6 million, compared to $177.0 million as of... More

